Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients (pts) with advanced NSCLC: Preliminary results of a phase II trial.

被引：0
|
作者：
Hanna, NH
Estes, D
Cress, A
Sidor, C
机构：
[1] Entremed, Rockville, MD USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7105
引用
收藏
页码：642S / 642S
页数：1
相关论文
共 50 条
  • [41] Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: A phase II study - Preliminary results
    Chougule, P
    Wanebo, H
    Akerley, W
    McRae, R
    Nigri, P
    Leone, L
    Safran, H
    Ready, N
    Koness, RJ
    Radie-Keane, K
    Cole, B
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S57 - S61
  • [42] Pharmacokinetics (PK) and pharmacodynamics of the carboplatin (CBDCA)/oxaliplatin (L-OHP) combination in patients (pts) with advanced malignancies: Preliminary results of an ongoing phase I trial
    Bekradda, M
    Chatelut, E
    Cvitkovic, E
    Soulie, P
    Canal, P
    Misset, JL
    Dupont-Andre, G
    Bensmaine, MA
    Bugat, R
    ANNALS OF ONCOLOGY, 1998, 9 : 117 - 117
  • [43] Preliminary results of the combination of paclitaxel and carboplatin for non small-cell lung cancer (NSCLC)
    Cunha, F
    Moraes, A
    Thereza, M
    Leistner, A
    Loureiro, K
    Cunha, G
    Cunha, L
    Najas, R
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 651 - 654
  • [44] Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
    Bertino, Erin M.
    Williams, Terence M.
    Nana-Sinkam, S. Patrick
    Shilo, Konstantin
    Chatterjee, Moumita
    Mo, Xiaokui
    Rahmani, Meliha
    Phillips, Gary S.
    Villalona-Calero, Miguel A.
    Otterson, Gregory A.
    CLINICAL LUNG CANCER, 2015, 16 (06) : 466 - +
  • [45] PHASE II TRIAL OF NAB-PACLITAXEL PLUS CARBOPLATIN IN PATIENTS WITH ADVANCED NSCLC AT RISK OF BLEEDING FROM VEGF DIRECTED THERAPIES
    Otterson, Gregory A.
    Bertino, Erin M.
    Karim, Nagla A.
    Donthireddy, Kavitha
    Ghany, Ahmed
    Rupert, Robert
    Cantrell, Sarah
    Rahmani, Meliha
    Lynn, Melinda
    Nana-Sinkam, S. P.
    Phillips, Gary S.
    Villalona-Calero, Miguel A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1288 - S1288
  • [46] Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma
    Clark, JI
    Hofmeister, C
    Choudhury, A
    Matz, G
    Collins, S
    Bastian, R
    Melian, E
    Emami, B
    Petruzzelli, G
    CANCER, 2001, 92 (09) : 2334 - 2340
  • [47] Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer
    Loesch, D
    Robert, N
    Asmar, L
    Gregurich, MA
    O'Rourke, M
    Dakhil, S
    Cox, E
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3857 - 3864
  • [48] Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer
    Johannsen, M
    Sachs, M
    Roigas, J
    Hinke, A
    Staack, A
    Loening, SA
    Schnorr, D
    Wille, AH
    EUROPEAN UROLOGY, 2005, 48 (02) : 246 - 251
  • [49] Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients With Locally Advanced Carcinoma of the Bladder COMMENT
    Tagawa, Scott T.
    JOURNAL OF UROLOGY, 2008, 180 (06): : 2388 - 2388
  • [50] Characterization of advanced NSCLC patients with prolonged benefit after veliparib plus carboplatin/paclitaxel: Phase 2 results
    Juhasz, E.
    Ramalingam, S.
    Blais, N.
    Mazieres, J.
    Reck, M.
    Jones, M.
    Urban, L.
    Orlov, S.
    Barlesi, F.
    Kio, E.
    Keilholz, U.
    Qian, J.
    Qin, Q.
    Ansell, P.
    Dziubinski, J.
    Nickner, C.
    McKee, M.
    Giranda, V.
    Gorbunova, V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S629 - S630
12345